{"id":7818,"date":"2012-01-23T00:00:00","date_gmt":"2012-01-22T22:00:00","guid":{"rendered":"https:\/\/irb.usi.ch\/uncategorized\/eu-invests-in-a-research-with-brazil-to-fight-inflammatory-disorders-the-irb-is-one-of-the-grantees\/"},"modified":"2012-01-23T00:00:00","modified_gmt":"2012-01-22T22:00:00","slug":"eu-invests-in-a-research-with-brazil-to-fight-inflammatory-disorders-the-irb-is-one-of-the-grantees","status":"publish","type":"post","link":"https:\/\/irb.usi.ch\/it\/news\/eu-invests-in-a-research-with-brazil-to-fight-inflammatory-disorders-the-irb-is-one-of-the-grantees\/","title":{"rendered":"EU invests in a research with Brazil to fight inflammatory disorders, the IRB is one of the grantees"},"content":{"rendered":"

on<\/span> January 23, 2012<\/span><\/p>\n

Takes place today in Bruxelles the kick-off meeting of the collaborative research programme \u2013 Targeting novel mechanisms of resolution in inflammation (TIMER) \u2013 which will accelerate the development of novel and powerful strategies to fight inflammation. TIMER is co-funded with \u20ac3M by the European Commission to establish robust collaboration with Brazil in the strategic area of inflammatory disorders with a high socio-economic impact. Scientists from 9 research partners in 4 European countries and 3 research partners in Brazil will collaborate in this new programme.<\/strong><\/p>\n

The IRB will participate with the group of Dr. Uguccioni that will study the expression and activity of key molecules (such as chemokines, cytokines and their receptors) which orchestrate the cell migration at inflammatory sites in pathological conditions such Inflammatory Bowel Diseases or Rheumatoid Arthritis.<\/p>\n

 \u201cThis is a unique opportunity for European scientists to strengthen ties with Brazilian colleagues addressing central issues related to inflammation, of broad potential in immune-based pathologies. The project will capitalize on productive interactions. The availability of natural resources, models of diseases, original paradigms and molecular approaches will be conducive to synergistic interactions\u201d says Alberto Mantovani, coordinator of TIMER and director of the Istituto Clinico Humanitas which is based in Milan \/ Italy.<\/p>\n

TIMER comprises a team of competitive European universities and research institutions next to top Brazilian groups. The project is reinforced by the presence of a pharmaceutical company and an SME for promoting translational research.<\/p>\n

From basic research to public health<\/strong><\/p>\n

This research programme covers a wide range of crucial aspects leading to resolution of inflammation; from discovery of novel natural compounds and basic research to clinical trials. The project will therefore lead to: improved collaboration with Brazilian scientists which have the privilege to have access to natural compounds acting on receptors which modulate inflammation, translation to the clinic available information and new data generated in the TIMER pipeline, and widespread knowledge on such an important theme for public health.<\/p>\n

Details of TIMER project<\/strong><\/p>\n

Start date: 01\/01\/2012
\n\tEnd date: 31\/12\/2015
\n\tProject cost: \u20ac4 million
\n\tEU contribution: \u20ac3 million
\n\tCoordinator: Alberto Mantovani, Fondazione Humanitas per la Ricerca, Rozzano (Milano) \u2013 Italy<\/p>\n

email: info@altaweb.eu<\/a>
\n\t <\/p>\n

Participants<\/strong><\/p>\n

Fondazione Humanitas per la Ricerca, Italy<\/p>\n

Universidade Federal de Minas Gerais, Brazil<\/p>\n

Universidade of Sao Paulo, Brazil<\/p>\n

Fundacao Oswaldo Cruz, Brazil<\/p>\n

Fondazione per l\u2019Istituto di Ricerca in Biomedicina, Switzerland<\/p>\n

University of Glasgow, United Kingdom<\/p>\n

Telormedix SA, Switzerland<\/p>\n

The Provost Fellows & Scholars of the Holy and Undivided<\/p>\n

Trinity of Queen Elizabeth near Dublin, Ireland<\/p>\n

Merck Serono SA, Switzerland<\/p>\n

ALTA Ricerca e Sviluppo in Biotecnologie S.r.l.u., Italy<\/p>\n","protected":false},"excerpt":{"rendered":"

on January 23, 2012 Takes place today in Bruxelles the kick-off meeting of the collaborative research programme \u2013 Targeting novel mechanisms of resolution in inflammation (TIMER) \u2013 which will accelerate the development of novel and powerful strategies to fight inflammation. TIMER is co-funded with \u20ac3M by the European Commission to establish robust collaboration with Brazil […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[16],"tags":[],"yoast_head":"\nEU invests in a research with Brazil to fight inflammatory disorders, the IRB is one of the grantees - IRB USI<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irb.usi.ch\/it\/news\/eu-invests-in-a-research-with-brazil-to-fight-inflammatory-disorders-the-irb-is-one-of-the-grantees\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EU invests in a research with Brazil to fight inflammatory disorders, the IRB is one of the grantees - IRB USI\" \/>\n<meta property=\"og:description\" content=\"on January 23, 2012 Takes place today in Bruxelles the kick-off meeting of the collaborative research programme \u2013 Targeting novel mechanisms of resolution in inflammation (TIMER) \u2013 which will accelerate the development of novel and powerful strategies to fight inflammation. TIMER is co-funded with \u20ac3M by the European Commission to establish robust collaboration with Brazil […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irb.usi.ch\/it\/news\/eu-invests-in-a-research-with-brazil-to-fight-inflammatory-disorders-the-irb-is-one-of-the-grantees\/\" \/>\n<meta property=\"og:site_name\" content=\"IRB USI\" \/>\n<meta property=\"article:published_time\" content=\"2012-01-22T22:00:00+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tempo di lettura stimato\">\n\t<meta name=\"twitter:data1\" content=\"2 minuti\">\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irb.usi.ch\/it\/#website\",\"url\":\"https:\/\/irb.usi.ch\/it\/\",\"name\":\"IRB USI\",\"description\":\"Institute for Research in Biomedicine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/irb.usi.ch\/it\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irb.usi.ch\/it\/news\/eu-invests-in-a-research-with-brazil-to-fight-inflammatory-disorders-the-irb-is-one-of-the-grantees\/#webpage\",\"url\":\"https:\/\/irb.usi.ch\/it\/news\/eu-invests-in-a-research-with-brazil-to-fight-inflammatory-disorders-the-irb-is-one-of-the-grantees\/\",\"name\":\"EU invests in a research with Brazil to fight inflammatory disorders, the IRB is one of the grantees - IRB USI\",\"isPartOf\":{\"@id\":\"https:\/\/irb.usi.ch\/it\/#website\"},\"datePublished\":\"2012-01-22T22:00:00+00:00\",\"dateModified\":\"2012-01-22T22:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/irb.usi.ch\/it\/#\/schema\/person\/c9b66c69925e1b0c558072acbadf4156\"},\"breadcrumb\":{\"@id\":\"https:\/\/irb.usi.ch\/it\/news\/eu-invests-in-a-research-with-brazil-to-fight-inflammatory-disorders-the-irb-is-one-of-the-grantees\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irb.usi.ch\/it\/news\/eu-invests-in-a-research-with-brazil-to-fight-inflammatory-disorders-the-irb-is-one-of-the-grantees\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irb.usi.ch\/it\/news\/eu-invests-in-a-research-with-brazil-to-fight-inflammatory-disorders-the-irb-is-one-of-the-grantees\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"item\":{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irb.usi.ch\/it\/\",\"url\":\"https:\/\/irb.usi.ch\/it\/\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"position\":2,\"item\":{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irb.usi.ch\/.\/news\/\",\"url\":\"https:\/\/irb.usi.ch\/.\/news\/\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"position\":3,\"item\":{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irb.usi.ch\/it\/news\/eu-invests-in-a-research-with-brazil-to-fight-inflammatory-disorders-the-irb-is-one-of-the-grantees\/\",\"url\":\"https:\/\/irb.usi.ch\/it\/news\/eu-invests-in-a-research-with-brazil-to-fight-inflammatory-disorders-the-irb-is-one-of-the-grantees\/\",\"name\":\"EU invests in a research with Brazil to fight inflammatory disorders, the IRB is one of the grantees\"}}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/irb.usi.ch\/it\/#\/schema\/person\/c9b66c69925e1b0c558072acbadf4156\",\"name\":\"AD_Dave\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","_links":{"self":[{"href":"https:\/\/irb.usi.ch\/it\/wp-json\/wp\/v2\/posts\/7818"}],"collection":[{"href":"https:\/\/irb.usi.ch\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/irb.usi.ch\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/irb.usi.ch\/it\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/irb.usi.ch\/it\/wp-json\/wp\/v2\/comments?post=7818"}],"version-history":[{"count":0,"href":"https:\/\/irb.usi.ch\/it\/wp-json\/wp\/v2\/posts\/7818\/revisions"}],"wp:attachment":[{"href":"https:\/\/irb.usi.ch\/it\/wp-json\/wp\/v2\/media?parent=7818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/irb.usi.ch\/it\/wp-json\/wp\/v2\/categories?post=7818"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/irb.usi.ch\/it\/wp-json\/wp\/v2\/tags?post=7818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}